Brown Brothers Harriman & Co. Has $98,000 Stock Holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Brown Brothers Harriman & Co. reduced its position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 32.9% in the 2nd quarter, according to its most recent filing with the SEC. The fund owned 8,141 shares of the pharmacy operator’s stock after selling 4,000 shares during the period. Brown Brothers Harriman & Co.’s holdings in Walgreens Boots Alliance were worth $98,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Atlas Brown Inc. raised its position in shares of Walgreens Boots Alliance by 1.8% in the first quarter. Atlas Brown Inc. now owns 31,593 shares of the pharmacy operator’s stock valued at $685,000 after purchasing an additional 550 shares during the period. Shilanski & Associates Inc. raised its holdings in Walgreens Boots Alliance by 5.3% in the 1st quarter. Shilanski & Associates Inc. now owns 11,821 shares of the pharmacy operator’s stock valued at $256,000 after acquiring an additional 591 shares during the period. First Trust Direct Indexing L.P. lifted its position in Walgreens Boots Alliance by 1.9% during the first quarter. First Trust Direct Indexing L.P. now owns 32,085 shares of the pharmacy operator’s stock worth $696,000 after acquiring an additional 597 shares during the last quarter. CreativeOne Wealth LLC boosted its holdings in shares of Walgreens Boots Alliance by 7.3% during the fourth quarter. CreativeOne Wealth LLC now owns 10,124 shares of the pharmacy operator’s stock worth $264,000 after acquiring an additional 688 shares during the period. Finally, Buckley Wealth Management LLC grew its position in shares of Walgreens Boots Alliance by 2.1% in the first quarter. Buckley Wealth Management LLC now owns 37,335 shares of the pharmacy operator’s stock valued at $810,000 after purchasing an additional 785 shares during the last quarter. Institutional investors own 58.59% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research analysts have weighed in on the company. JPMorgan Chase & Co. lowered their price objective on Walgreens Boots Alliance from $20.00 to $15.00 and set an “overweight” rating on the stock in a research report on Friday, August 30th. Truist Financial cut their price objective on shares of Walgreens Boots Alliance from $20.00 to $13.00 and set a “hold” rating for the company in a report on Friday, June 28th. Evercore ISI lowered their target price on shares of Walgreens Boots Alliance from $17.00 to $10.00 and set an “in-line” rating on the stock in a report on Friday, June 28th. Royal Bank of Canada cut their price target on Walgreens Boots Alliance from $22.00 to $13.00 and set a “sector perform” rating for the company in a research note on Tuesday, July 2nd. Finally, Bank of America lowered their price objective on Walgreens Boots Alliance from $11.00 to $7.50 and set an “underperform” rating on the stock in a research note on Wednesday, September 4th. Four research analysts have rated the stock with a sell rating, ten have issued a hold rating and two have given a buy rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Hold” and an average price target of $14.73.

Walgreens Boots Alliance Stock Performance

Shares of Walgreens Boots Alliance stock opened at $9.01 on Thursday. The company’s 50 day moving average price is $10.40 and its two-hundred day moving average price is $14.89. The firm has a market capitalization of $7.78 billion, a P/E ratio of -1.34, a P/E/G ratio of 1.02 and a beta of 0.70. Walgreens Boots Alliance, Inc. has a fifty-two week low of $8.46 and a fifty-two week high of $27.05. The company has a debt-to-equity ratio of 0.49, a current ratio of 0.65 and a quick ratio of 0.31.

Walgreens Boots Alliance (NASDAQ:WBA) last released its quarterly earnings data on Thursday, June 27th. The pharmacy operator reported $0.63 earnings per share for the quarter, missing the consensus estimate of $0.68 by ($0.05). The firm had revenue of $36.40 billion for the quarter, compared to analyst estimates of $35.94 billion. Walgreens Boots Alliance had a negative net margin of 3.99% and a positive return on equity of 12.63%. The company’s revenue was up 2.8% compared to the same quarter last year. During the same period last year, the business earned $1.00 EPS. On average, equities analysts forecast that Walgreens Boots Alliance, Inc. will post 2.86 earnings per share for the current fiscal year.

Walgreens Boots Alliance Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Thursday, September 12th. Stockholders of record on Wednesday, August 21st were paid a dividend of $0.25 per share. This represents a $1.00 annualized dividend and a dividend yield of 11.10%. The ex-dividend date was Wednesday, August 21st. Walgreens Boots Alliance’s payout ratio is currently -14.84%.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.